Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

PCOS is a hormonal disorder causing infertility and menstrual problems, often linked to obesity and can lead to acne, treated with hormonal and insulin-sensitizing medications.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.